Paul-Ehrlich-Institut

Go to:

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Issue 2/2019 of the Pharmacovigilance Bulletin

Cover Pharmacovigilance Bulletin - Information from BfArM and PEI (Source: PEI)

The second edition 2019 of the "Pharmacovigilance Bulletin - Information from BfArM and PEI" was published on 27.06.2019.

The Pharmacovigilance Bulletin is published jointly by the Federal Institute for Drugs and Medical Devices (BfArM) and the Paul-Ehrlich-Institut (PEI). With the quarterly bulletin, both federal institutes provide information on current aspects of the risk assessment of pharmaceuticals. The focus is on pharmacovigilance - the continuous monitoring and evaluation of drug safety before and after approval. The Bulletin includes contributions to individual medicines as well as background information on understanding pharmacovigilance and research in this area.

Pharmacovigilance Bulletin, Issue 2/2019 (German only)


Further information:

Archive of Pharmacovigilance Bulletin (German Only): www.pei.de/bulletin-safety

Updated: 27.06.2019